Product Images Quetiapine Extended Release

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Quetiapine Extended Release NDC 10135-659 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The structural formula for Quetiapine extended-release tablets are an atypical antipsychotic belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4] thiazepin-11-yl- 1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It is present in tablets as the fumarate salt. All doses and tablet strengths are expressed as milligrams of base, not as fumarate salt. Its molecular formula is C42H50N6O4S2•C4H4O4 and it has a molecular weight of 883.11 (fumarate salt). - quetiapine extended release 01

The structural formula for Quetiapine extended-release tablets are an atypical antipsychotic belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4] thiazepin-11-yl- 1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It is present in tablets as the fumarate salt. All doses and tablet strengths are expressed as milligrams of base, not as fumarate salt. Its molecular formula is C42H50N6O4S2•C4H4O4 and it has a molecular weight of 883.11 (fumarate salt). - quetiapine extended release 01

Figure 1 Kaplan-Meier Curves of Time to Schizophrenic Relapse (study 3) - quetiapine extended release 02

Figure 1 Kaplan-Meier Curves of Time to Schizophrenic Relapse (study 3) - quetiapine extended release 02

Figure 2 Kaplan-Meier Curves of Time to Recurrence of A Mood Event (Study 9) - quetiapine extended release 03

Figure 2 Kaplan-Meier Curves of Time to Recurrence of A Mood Event (Study 9) - quetiapine extended release 03

Figure 3 Kaplan-Meier Curves of Time to Recurrence of A Mood Event (Study 10) - quetiapine extended release 04

Figure 3 Kaplan-Meier Curves of Time to Recurrence of A Mood Event (Study 10) - quetiapine extended release 04

PRINCIPAL DISPLAY PANELNDC 10135-0656-60Quetiapine Extended-Release Tablets, USP150 mg Once Daily60 TABLETSRx Only - quetiapine extended release 05

PRINCIPAL DISPLAY PANELNDC 10135-0656-60Quetiapine Extended-Release Tablets, USP150 mg Once Daily60 TABLETSRx Only - quetiapine extended release 05

NDC 10135-0656-60 is a medication manufactured and distributed by Marlex Pharmaceuticals. Each tablet contains 172.7 mg of quetiapine fumarate, equivalent to 150 mg of quetiapine. The medication should be swallowed whole and not split, crushed, or chewed. The usual dosage is once daily, as indicated by the prescribing information. Quetiapine should be stored at 25°C (77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication should be kept out of the reach of children.*

PRINCIPAL DISPLAY PANELNDC 10135-0657-60Quetiapine Extended-Release Tablets, USP200 mg Once Daily60 TABLETSRx Only - quetiapine extended release 06

PRINCIPAL DISPLAY PANELNDC 10135-0657-60Quetiapine Extended-Release Tablets, USP200 mg Once Daily60 TABLETSRx Only - quetiapine extended release 06

This is a description of a medication called Quetiapine, with the National Drug Code 10135-0657-60, manufactured and distributed by Marlex Pharmaceuticals. Each tablet contains 230.26mg of Quetiapine Fumarate equivalent to 200mg of Quetiapine. The tablets must be swallowed whole, and not crushed or chewed. The recommended dosage is once daily, and users should consult the accompanying prescribing information before use. The medication should be stored at 25°C (77°F) with excursions of 15° to 30°C (59°F to 86°F) allowed. The medication must be kept out of the reach of children. The package contains 60 tablets.*

PRINCIPAL DISPLAY PANELNDC 10135-0658-60Quetiapine Extended-Release Tablets, USP300 mg Once Daily60 TABLETSRx Only - quetiapine extended release 07

PRINCIPAL DISPLAY PANELNDC 10135-0658-60Quetiapine Extended-Release Tablets, USP300 mg Once Daily60 TABLETSRx Only - quetiapine extended release 07

This is a description of a medication with the National Drug Code (NDC) 10135-0658-60. Each tablet contains 345.38 mg of quetiapine fumarate, which is equivalent to 300 mg of quetiapine. The medication should be swallowed whole and should not be split, crushed, or chewed. The usual dosage is once daily, and the medication should be stored at room temperature. The medication is manufactured and distributed by Marlex Pharmaceuticals, Inc. This information is included with the prescribing information.*

PRINCIPAL DISPLAY PANELNDC 10135-0659-60Quetiapine Extended-Release Tablets, USP400 mg Once Daily60 TABLETSRx Only - quetiapine extended release 08

PRINCIPAL DISPLAY PANELNDC 10135-0659-60Quetiapine Extended-Release Tablets, USP400 mg Once Daily60 TABLETSRx Only - quetiapine extended release 08

This is a medication description for Quetiapine, also known as NDC 10135-0659-60. Each tablet contains 460.5 mg of quetiapine fumarate equivalent to 400 mg of quetiapine. The medication is meant to be swallowed whole and not split, crushed, or chewed. The recommended dosage is once daily, and specific prescribing information should be consulted. The medication should be stored at room temperature, between 15-30°C. This medication is distributed by Marlex Pharmaceuticals and comes in a bottle with 60 tablets.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.